Downloads: 1
| # | Blank 1 | Frequency | Blank 2 | Frequency | Blank 3 | Frequency | Blank 4 | Frequency | Blank 5 | Frequency | Blank 6 | Frequency | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | chronic active hepatitis b patient may | 3 | 5 | core antibody positive for patients with concomitant positive hepatitis b | 3 | patient will require a hepatology consmcLtation the risk / benefit profile of transplant | 3 | b will be discussed | 5 | the patient and eligibility determined by the pi or lead associate investigator | 1 | |
| 2 | 1 | recipient chronic active hepatitis b patient may | 1 | hiv negative | 1 | core antibody positive for patients with a concomitant positive hepatitis b | 2 | patients will require a hepatology consmcLtation the risk benefit profile of transplant | 2 | c antibody negative donors | 1 | the patient and eligibility determined by the pi and the protocol chairperson | 1 |
| 3 | 4 | chronic active hepatitis b patients may | 1 | NA | 1 | negative | 1 | NA | the patient and eligibility determined by the principal investigator and lai | 1 | |||
| 4 | 6 | donor donors must | 1 | NA | NA | NA | NA | the patient and eligibility determined by the principal investigator | 1 | ||||
| 5 | 3 | NA | NA | NA | NA | NA | the patient and eligibility determined by the principal investigator and protocol chairperson | 1 | |||||
| 6 | 5 | NA | NA | NA | NA | NA | a history of hepatitis b or hepatitis c infection may be eligible however | 1 |